Related Articles
Randomized phase II study of sequential carboplatin plus paclitaxel and gefitinib in chemotherapy‑naïve patients with advanced or metastatic non‑small‑cell lung cancer: Long‑term follow‑up results
Hand-foot syndrome in a patient with metastatic lung adenocarcinoma induced by high-dose icotinib: A case report and review of the literature
Comparison of effectiveness and adverse effects of gefitinib, erlotinib and icotinib among patients with non‑small cell lung cancer: A network meta‑analysis
Clinical observation of gefitinib as a first-line therapy in sixty-eight patients with advanced NSCLC
A population-based study of gefitinib in patients with postoperative recurrent non-small cell lung cancer